W Stadler. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Carcinoma, Renal Cell/immunologyCarcinoma, Renal Cell/therapyHumansImmunotherapyInterferon-alpha/therapeutic useInterleukin-2/therapeutic useKidney Neoplasms/immunologyKidney Neoplasms/therapyPrognosisTreatment Outcome
Substances: See more » Interferon-alphaInterleukin-2
Year: 2000 PMID: 10834033 DOI: 10.3109/07357900009032820
Source DB: PubMed Journal: Cancer Invest ISSN: 0735-7907 Impact factor: 2.176